These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26696595)

  • 1. Endothelial progenitor cells as markers of severity in hypertrophic cardiomyopathy.
    Kalyva A; Marketou ME; Parthenakis FI; Pontikoglou C; Kontaraki JE; Maragkoudakis S; Petousis S; Chlouverakis G; Papadaki HA; Vardas PE
    Eur J Heart Fail; 2016 Feb; 18(2):179-84. PubMed ID: 26696595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells mobilization after maximal exercise according to heart failure severity.
    Kourek C; Karatzanos E; Psarra K; Georgiopoulos G; Delis D; Linardatou V; Gavrielatos G; Papadopoulos C; Nanas S; Dimopoulos S
    World J Cardiol; 2020 Nov; 12(11):526-539. PubMed ID: 33312438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating mesenchymal stem cells in patients with hypertrophic cardiomyopathy.
    Marketou ME; Parthenakis FI; Kalyva A; Pontikoglou C; Maragkoudakis S; Kontaraki JE; Zacharis EA; Patrianakos A; Chlouverakis G; Papadaki HA; Vardas PE
    Cardiovasc Pathol; 2015; 24(3):149-53. PubMed ID: 25744383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
    Lanuti P; Rotta G; Almici C; Avvisati G; Budillon A; Doretto P; Malara N; Marini M; Neva A; Simeone P; Di Gennaro E; Leone A; Falda A; Tozzoli R; Gregorj C; Di Cerbo M; Trunzo V; Mollace V; Marchisio M; Miscia S
    Cytometry A; 2016 Mar; 89(3):259-70. PubMed ID: 26305912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?
    António N; Soares A; Carvalheiro T; Fernandes R; Paiva A; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA; Ribeiro CF; Pego GM
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):731-9. PubMed ID: 24383551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.
    Guerin CL; Guyonnet L; Goudot G; Revets D; Konstantinou M; Chipont A; Chocron R; Blandinieres A; Khider L; Rancic J; Peronino C; Debuc B; Cras A; Knosp C; Latremouille C; Capel A; Ollert M; Diehl JL; Jansen P; Planquette B; Sanchez O; Gaussem P; Mirault T; Carpentier A; Gendron N; Smadja DM
    Stem Cell Rev Rep; 2021 Apr; 17(2):639-651. PubMed ID: 33205351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Boltin D; Kamenetsky Z; Perets TT; Snir Y; Sapoznikov B; Schmilovitz-Weiss H; Ablin JN; Dickman R; Niv Y
    Dig Dis Sci; 2017 Mar; 62(3):633-638. PubMed ID: 27339637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.
    Maiorino MI; Bellastella G; Petrizzo M; Della Volpe E; Orlando R; Giugliano D; Esposito K
    Endocrine; 2015 Jun; 49(2):415-21. PubMed ID: 25411101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness.
    Marketou ME; Kalyva A; Parthenakis FI; Pontikoglou C; Maragkoudakis S; Kontaraki JE; Chlouverakis G; Zacharis EA; Patrianakos A; Papadaki HA; Vardas PE
    J Clin Hypertens (Greenwich); 2014 Apr; 16(4):295-300. PubMed ID: 24641802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered circulating endothelial progenitor cells in patients with keloid.
    Zhang GY; Wu LC; Liao T; Chen G; Chen YH; Meng XC; Wang AY; Chen SY; Lin K; Lin DM; Gao WY; Li QF
    Clin Exp Dermatol; 2016 Mar; 41(2):152-5. PubMed ID: 26121920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study.
    Obeid J; Nguyen T; Cellucci T; Larché MJ; Timmons BW
    Pediatr Rheumatol Online J; 2015 Oct; 13(1):41. PubMed ID: 26458943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
    Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
    Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressed increase in blood endothelial progenitor cell content as result of single exhaustive exercise bout in male revascularised coronary artery disease patients.
    Rummens JL; Daniëls A; Dendale P; Hensen K; Hendrikx M; Berger J; Koninckx R; Hansen D
    Acta Clin Belg; 2012; 67(4):262-9. PubMed ID: 23019801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells as a biological marker of peripheral artery disease.
    Bitterli L; Afan S; Bühler S; DiSanto S; Zwahlen M; Schmidlin K; Yang Z; Baumgartner I; Diehm N; Kalka C
    Vasc Med; 2016 Feb; 21(1):3-11. PubMed ID: 26511986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.